Exelixis (EXEL) Prepaid Assets (2010 - 2026)
Exelixis (EXEL) recorded quarterly Prepaid Assets of $75.9 million in Q2 2026, little changed quarter-over-quarter from $75.6 million in Q1 2026, and up 29.27% on a YoY basis from $58.7 million in Q2 2025.
Exelixis (EXEL) Prepaid Assets (2010 - 2026) Analysis & Trends
Exelixis' Prepaid Assets history runs 17 years deep, the most recent figure standing at $75.9 million for Q2 2026.
- In Q2 2026, Prepaid Assets rose 29.27% year-over-year to $75.9 million; the TTM figure through Apr 2026 stood at $75.9 million (up 29.27% YoY), while the FY2026 annual figure was $75.6 million, up 10.39% from the prior year.
- Prepaid Assets was $75.9 million for Q2 2026 at Exelixis, roughly flat from $75.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $76.6 million in Q4 2025 to a low of $48.3 million in Q3 2022.
- Historically, Prepaid Assets has averaged $64.7 million across 5 years, with a median of $66.9 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets dropped 13.03% in 2025, then climbed 29.27% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $62.2 million in 2022, then increased by 9.19% to $67.9 million in 2023, then advanced by 2.81% to $69.8 million in 2024, then advanced by 9.68% to $76.6 million in 2025, then declined by 0.94% to $75.9 million in 2026.
- The last three Prepaid Assets figures came in at $75.9 million (Q2 2026), $75.6 million (Q1 2026), and $76.6 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Exelixis | 13.71 Bn | 12.93 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 75.88 Mn |
| Jan 2, 2026 | 75.60 Mn |
| Oct 3, 2025 | 76.60 Mn |
| Jul 4, 2025 | 73.83 Mn |
| Apr 4, 2025 | 58.70 Mn |
| Jan 3, 2025 | 68.48 Mn |
| Sep 27, 2024 | 69.84 Mn |
| Jun 28, 2024 | 58.25 Mn |
| Mar 29, 2024 | 67.49 Mn |
| Dec 29, 2023 | 67.93 Mn |
| Sep 29, 2023 | 66.89 Mn |
| Jun 30, 2023 | 62.26 Mn |
| Mar 31, 2023 | 60.65 Mn |
| Dec 30, 2022 | 62.21 Mn |
| Sep 30, 2022 | 52.90 Mn |
| Jul 1, 2022 | 48.28 Mn |
| Apr 1, 2022 | 53.33 Mn |
| Dec 31, 2021 | 57.53 Mn |
| Oct 1, 2021 | 51.56 Mn |
| Jul 2, 2021 | 49.88 Mn |